Protecting health-care workers from subclinical coronavirus infection. 2020

De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
Department of Respiratory Medicine, Third Medical Center of Chinese PLA General Hospital, Beijing, China; Section of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

UI MeSH Term Description Entries
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D006282 Health Personnel Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976) Health Care Professionals,Health Care Providers,Healthcare Providers,Healthcare Workers,Health Care Professional,Health Care Provider,Healthcare Provider,Healthcare Worker,Personnel, Health,Professional, Health Care,Provider, Health Care,Provider, Healthcare
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067393 Personal Protective Equipment Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear. PPE Personal Protective Equipment,Equipment, Personal Protective,Personal Protective Equipments,Protective Equipment, Personal
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D058345 Asymptomatic Infections Infections that do not exhibit symptoms. Asymptomatic Colonization,Inapparent Infections,Presymptomatic Infections,Subclinical Infections,Asymptomatic Colonizations,Asymptomatic Infection,Colonization, Asymptomatic,Inapparent Infection,Infection, Asymptomatic,Infection, Inapparent,Infection, Presymptomatic,Infection, Subclinical,Presymptomatic Infection,Subclinical Infection
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
August 1987, Hospital material[dollar sign] management,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
July 2008, Journal of occupational and environmental medicine,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
October 2011, AAOHN journal : official journal of the American Association of Occupational Health Nurses,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
November 1994, Communicable disease report. CDR weekly,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
August 1993, Communicable disease report. CDR weekly,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
March 2020, Lancet (London, England),
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
June 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
May 2020, JAMA network open,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
October 2009, American journal of infection control,
De Chang, and Huiwen Xu, and Andre Rebaza, and Lokesh Sharma, and Charles S Dela Cruz
May 1988, QRB. Quality review bulletin,
Copied contents to your clipboard!